Phase I Trial of Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy with Nanoliposomal Irinotecan in Patients with Peritoneal Surface Cancers

Grants and Contracts Details


Assess the feasibility and safety of intraperitoneal administration of heated nanoliposomal irinotecan in CRS and HlPEC procedures. I) Determine the correlation of intraperitoneal dosages of nanoliposomal irinotecan with plasma blood levels using pharmacokinetic analysis. 2) Assess the efficacy of intraperitoneal administration of nanoliposomal irinotecan relating to disease free survival.
Effective start/end date1/28/203/31/23


  • Research Foundation of State University of New York: $235,000.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.